SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
This Item 5.07 disclosure reports the results of CME Group's 2026 Annual Meeting of Shareholders held on May 14, 2026, including voting outcomes on director elections (14 equity directors), auditor ratification (Ernst & Young LLP), and advisory compensation approval. The filing presents detailed vote tallies (FOR, AGAINST, ABSTAIN) for each proposal, which is the core content of shareholder vote result disclosures required under Item 5.07.
View raw filing on EDGAR →NOVAGOLD held its 2026 Annual Meeting of Shareholders on May 14, 2026, with voting results on seven proposals including director elections, auditor appointment, stock plan amendments, and executive compensation resolutions. The filing reports the complete voting tallies for all proposals, reflecting shareholder approval of governance and equity plan matters.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from ServisFirst Bancshares' 2026 Annual Meeting held on May 18, 2026. The filing reports final voting tallies for three matters: election of seven directors (all elected), advisory vote on named executive officer compensation (approved), and ratification of Forvis Mazars, LLP as independent auditor (approved). The detailed vote counts for each director and proposal are provided, matching the Item 5.07 requirement for shareholder vote results disclosure.
View raw filing on EDGAR →The filing discloses the appointment of Keith D. Rose, M.D. as Chief Medical Officer, effective May 1, 2026. This is a material executive appointment to a senior leadership position. Dr. Rose's extensive background in medical affairs and clinical leadership across major pharmaceutical companies (Novocure, Ipsen, Jazz Pharmaceuticals, Indivior) demonstrates the significance of this hire to the Company's medical and clinical strategy.
View raw filing on EDGAR →The filing discloses fiscal 2026 and fiscal fourth quarter financial results announced via press release on May 19, 2026, under Item 2.02 (Results of Operations and Financial Condition). Item 7.01 confirms the earnings announcement and notes a scheduled earnings call. The press release is furnished as Exhibit 99.1, which is the standard format for earnings disclosures in 8-K filings.
View raw filing on EDGAR →Item 2.02 disclosure of quarterly and fiscal year financial results for the period ended March 31, 2026, with an earnings press release furnished as Exhibit 99.1. This is a standard earnings announcement that would materially affect investor assessment of the company's financial performance.
View raw filing on EDGAR →Korro Bio announced the addition of KRRO-111 for Alpha-1 Antitrypsin Deficiency to its pipeline, disclosed via press release and updated investor presentation. While this represents a material pipeline expansion for a clinical-stage biotech company that would affect investor assessment of the company's development strategy and future prospects, it does not fit neatly into the more specific event categories (not an earnings release, M&A activity, impairment, or other defined event types). This is best classified as other_material.
View raw filing on EDGAR →FMC announced a proposed $750 million private offering of senior secured notes due 2031 to refinance existing debt and for general corporate purposes. While this is a material financing event affecting the company's capital structure and liquidity, it does not fit cleanly into the standard taxonomy categories (not an M&A activity, not a dilutive equity issuance, not a covenant breach). The disclosure centers on the announcement of a debt offering rather than completion of a transaction, making "other_material" the most appropriate classification for this significant financing announcement.
View raw filing on EDGAR →The filing discloses multiple executive appointments on May 18, 2026: Dr. Miralles as President and Head of R&D (with $600,000 base salary, 45% bonus target, and substantial equity grants of 232,500 options and 77,500 RSUs), and Dr. Aslan as principal financial and accounting officer. While the section also includes departures (Dr. Miralles from the Board, Dr. Aslan from President, and Thad Huston as CFO), the principal disclosed actions center on the appointments of these executives to new roles with defined compensation packages, making exec_appointment the most salient classification.
View raw filing on EDGAR →The Company disclosed a private offering of Convertible Senior Notes due 2032 to qualified institutional buyers pursuant to Rule 144A. Convertible notes are dilutive securities that may result in issuance of Class A common stock upon conversion, making this a dilutive issuance material to investors assessing capital structure and potential equity dilution.
View raw filing on EDGAR →Relay Therapeutics announced initial Phase 2 clinical trial data from the ReInspire study of zovegalisib in vascular anomalies, reporting a 60% volumetric response rate in 20 evaluable patients, 89% clinical improvement in patient-reported outcomes (IGIC), and low Grade 3+ adverse event rates at lower doses.
View raw filing on EDGAR →This Item 2.03 disclosure reports the creation of direct financial obligations through the issuance of consolidated obligations (bonds and discount notes) by the Federal Home Loan Bank of Pittsburgh. While the filing explicitly states "consolidated obligations issuance is material to the FHLBank," the disclosure is primarily informational and regulatory in nature—describing the mechanics of consolidated obligation issuance, the joint and several liability structure, and referencing Schedule A for specific debt instruments. This does not fit cleanly into covenant_breach (no violation alleged) or the more specific debt-related categories, making other_material the most appropriate classification for this regulatory debt disclosure.
View raw filing on EDGAR →The filing discloses a press release announcing "expected quarterly revenue results for its fiscal 2026 year ended March 31, 2026," which is a classic earnings release disclosure under Item 2.02. The press release is furnished as Exhibit 99.1, a standard format for earnings announcements. This is material to investors as it provides financial performance data for the fiscal year.
View raw filing on EDGAR →Mister Car Wash, Inc. was acquired in a merger at $7.00 per share in cash, with the transaction consummated on May 19, 2026. The merger was funded by a $900 million senior secured first lien incremental term loan facility, and resulted in the conversion of all common stock into cash consideration, termination of equity plans, and immediate delisting from NASDAQ.
View raw filing on EDGAR →On May 19, 2026, Mister Car Wash notified NASDAQ of the merger consummation and requested delisting of its common stock (ticker 'MCW') via Form 25 filing. Trading was suspended prior to market open, and the company intends to file Form 15 to deregister and terminate reporting obligations.
View raw filing on EDGAR →Kennametal announced a cash tender offer for its 4.625% Senior Notes due 2028 and a concurrent underwritten public offering of senior notes. While this involves debt refinancing activity, it does not fit cleanly into the M&A taxonomy (which focuses on acquisitions, dispositions, mergers, or changes of control). The tender offer and new debt issuance are material financing transactions that would affect investor assessment of the company's capital structure and liquidity, but lack a more specific event classification.
View raw filing on EDGAR →The Trust disclosed receipt of a Schedule 13D filed by SoftVest relating to a "proposed business combination involving the Trust." The disclosure explicitly references a potential merger or change-of-control transaction, with anticipated Form S-4 filing and unitholder meeting. This constitutes material M&A activity under Item 1.01 or 2.01 framework, even though disclosed via Item 7.01 (Regulation FD).
View raw filing on EDGAR →Medpace Holdings held its Annual Meeting of Stockholders on May 15, 2026, with voting results across seven proposals including election of five directors (Brian T. Carley, Femida H. Gwadry-Sridhar, Robert O. Kraft, August J. Troendle, Dani S. Zander), ratification of Deloitte & Touche LLP as auditor, advisory votes on executive compensation and voting frequency, and two Certificate of Incorporation amendments to remove supermajority voting requirements and expand special meeting rights.
View raw filing on EDGAR →Roper Technologies held its Annual Meeting of Shareholders on May 19, 2026, with voting results reported for six proposals: election of nine directors (approved), advisory compensation vote (approved), auditor ratification (approved), incentive plan amendment (approved), employee stock purchase plan amendment (approved), and a shareholder proposal on spin-off strategic review (not approved).
View raw filing on EDGAR →This is a clear Item 5.07 disclosure of shareholder vote results from CTS Corporation's Annual Meeting of Shareholders held on May 14, 2026. The filing reports final voting tallies for three proposals: election of eight directors (all elected), advisory approval of named executive officer compensation (approved), and ratification of Grant Thornton as independent auditor (approved). Shareholder voting outcomes are material to investors as they reflect governance decisions and stakeholder approval of key corporate matters.
View raw filing on EDGAR →The filing discloses that Nasdaq has notified Bitcoin Depot that trading of its Class A common stock and warrants will be suspended effective May 26, 2026, and a Form 25-NSE will be filed to remove the securities from listing and registration on Nasdaq. This is a direct delisting notice triggered by the company's Chapter 11 bankruptcy filing and failure to timely file its Form 10-Q, making this a clear delisting_risk event under Item 3.01.
View raw filing on EDGAR →The Company converted 42,839.11 shares of Series B Non-Voting Convertible Preferred Stock into 42,839,103 shares of common stock on May 15, 2026, resulting in a substantial increase in common share count (approximately 1,000x conversion ratio). This mandatory conversion of preferred stock into common stock is a dilutive issuance that materially increases the equity base and would affect a reasonable investor's assessment of ownership dilution and voting power, even though the conversion was contractually mandated under the Certificate of Designation.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure reporting the results of Invivyd's Annual Meeting of Stockholders held on May 19, 2026. The filing presents voting tallies for two proposals: (1) election of six directors (Tamsin Berry, Paul B. Bolno, Marc Elia, Terrance McGuire, Kevin F. McLaughlin, and Ajay Royan) for one-year terms, and (2) ratification of PricewaterhouseCoopers LLP as independent auditor. All nominees were elected and the auditor ratification passed with overwhelming support, making this a material governance event that investors rely on to understand board composition and audit oversight.
View raw filing on EDGAR →Lamar Advertising held its 2026 Annual Meeting of Stockholders on May 14, 2026, with shareholders voting on five proposals: election of ten directors, ratification of KPMG LLP as auditor, advisory approval of executive compensation, and approval of amendments to the 1996 Equity Incentive Plan and 2019 Employee Stock Purchase Plan. All proposals passed with substantial majorities.
View raw filing on EDGAR →The filing discloses the appointment of Jeff Newgard as President and Chief Executive Officer of GBank effective June 8, 2026, with detailed compensation terms including a $500,000 base salary, $100,000 sign-on bonus, equity grants of 20,000 restricted shares, and relocation assistance. While the section also mentions A. Lee Finley's resignation as a director, the principal and substantive disclosure centers on the executive appointment with comprehensive employment agreement details. This is a material executive appointment that would affect investor assessment of company leadership.
View raw filing on EDGAR →This is a clear disclosure of shareholder voting results from ATI Inc.'s 2026 Annual Meeting of Stockholders held on May 14, 2026. The filing presents detailed vote tallies for three proposals: election of three directors (Kimberly A. Fields, Elizabeth H. Lund, and David J. Morehouse), an advisory vote on named executive officer compensation, and ratification of Ernst & Young LLP as independent auditors. This is a quintessential Item 5.07 disclosure and is material to investors as it documents the outcomes of fundamental corporate governance matters.
View raw filing on EDGAR →Apollo Debt Solutions BDC sold 384,867 unregistered Class I Common Shares for $9.2 million to feeder vehicles, relying on Section 4(a)(2) and Regulation S exemptions. This private placement of equity securities materially affects shareholder ownership and capitalization.
View raw filing on EDGAR →Apollo Debt Solutions BDC declared May 2026 distributions on May 19, 2026, with per-share amounts ranging from $0.1627 to $0.1800 across three share classes, payable June 29, 2026, accompanied by material supplemental disclosure of NAV, performance metrics, portfolio composition ($25.7B across 404 companies), and leverage ratios.
View raw filing on EDGAR →Apollo Debt Solutions BDC provided a Net Asset Value and Portfolio Update as of April 30, 2026, disclosing NAV per share of $23.92, aggregate NAV of $14.5 billion, portfolio fair value of $25.7 billion, debt outstanding of $11.8 billion, and leverage ratios (0.81x debt-to-equity, 0.75x net leverage).
View raw filing on EDGAR →Patterson-UTI Energy completed a $500 million offering of senior notes on May 19, 2026, pursuant to a supplemental indenture. The proceeds are intended for redemption of existing debt and general corporate purposes, representing a material capital structure and financing event.
View raw filing on EDGAR →HPS Corporate Lending Fund entered into a material definitive agreement on May 19, 2026, to issue $600 million in aggregate principal amount of 6.300% notes due 2031, with net proceeds of approximately $594.3 million to be used for investments, reducing borrowings, and repaying indebtedness.
View raw filing on EDGAR →IRIDEX Corporation issued a press release on May 19, 2026 disclosing financial results for its first fiscal quarter ended April 4, 2026, filed under Item 2.02 (Results of Operations and Financial Condition). This is a standard quarterly earnings release, which is material to investors as it provides key financial performance metrics and operational updates.
View raw filing on EDGAR →Stockholders approved all five proposals at the Company's Annual Meeting held on May 13, 2026: election of five directors, ratification of Haskell & White LLP as auditors, amendment to the 2017 Equity Incentive Plan increasing authorized shares from 5,000,000 to 7,000,000, advisory approval of named executive officer compensation, and approval of meeting adjournment.
View raw filing on EDGAR →This is a clear Item 5.07 disclosure of shareholder voting results from Eastern Bankshares' May 18, 2026 annual meeting. The filing reports the outcomes of three proposals: election of six directors, advisory vote on executive compensation, and ratification of Ernst & Young LLP as independent auditor. All three votes passed with substantial majorities, and the detailed vote tallies (votes for, against, abstentions, and broker non-votes) are provided for each proposal.
View raw filing on EDGAR →The filing discloses the appointment of Andrea Brimmer to the Board of Directors of Primo Brands Corporation, effective May 15, 2026, to fill a newly created vacancy. While the Board size increase is administrative, the principal disclosed action is the appointment of a director with significant executive experience (Chief Marketing and Public Relations Officer at Ally Financial Inc. since 2015) and board service at other public companies. This is a material corporate governance event affecting the composition of the Board.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure reporting the results of the 2026 Annual Meeting of Stockholders held on May 15, 2026. The filing presents voting results for three proposals: election of three Class III directors (Edgar R. Giesinger, A. James Teague, and William A. Zartler), ratification of BDO USA, P.C. as independent auditor, and an advisory vote on named executive officer compensation. These are routine but material shareholder votes that affect board composition and auditor appointment.
View raw filing on EDGAR →Blackstone Digital Infrastructure Trust entered into material definitive agreements in connection with its initial public offering on May 15, 2026, including a Registration Rights Agreement, Management Agreement, and a $1.0 billion senior secured revolving credit facility with expansion capacity to $4.0 billion.
View raw filing on EDGAR →Blackstone Digital Infrastructure Trust completed its initial public offering of 87.5 million shares at $20.00 per share on May 15, 2026, with underwriters exercising a full 30-day option for additional shares, resulting in gross proceeds of $2.0 billion.
View raw filing on EDGAR →The Board adopted the Blackstone Digital Infrastructure Trust Inc. Stock Incentive Plan on May 13, 2026, establishing a long-term incentive plan governing equity grants for officers and directors.
View raw filing on EDGAR →The company disclosed a material modification to rights of security holders, with the substance incorporated by reference from Item 5.03, relating to amendments affecting shareholder rights.
View raw filing on EDGAR →This is a clear Item 5.07 disclosure of shareholder vote results from Nucor's May 14, 2026 annual meeting. The filing reports voting outcomes for three proposals: election of eight directors (all passed with strong majorities), ratification of PricewaterhouseCoopers LLP as independent auditor, and advisory approval of named executive officer compensation. The detailed vote tallies and passage of all proposals are the core content of this 8-K section.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure reporting the results of Millrose Properties' annual stockholder meeting held on May 18, 2026. The filing presents detailed vote tallies for two proposals: election of five directors (Carlos A. Migoya, Patrick J. Bartels, Kathleen B. Lynch, Matthew B. Gorson, and M. Alison Mincey) and ratification of Deloitte & Touche LLP as independent auditor. All directors were elected and the auditor ratification passed by overwhelming margins, making this a material governance event that affects investor understanding of board composition and audit oversight.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure of shareholder vote results from Larimar Therapeutics' 2026 Annual Meeting held on May 19, 2026. The filing reports final voting tallies for six proposals: election of three Class III directors (Frank Thomas, Carole S. Ben-Maimon, M.D., and Joseph Truitt), advisory approval of named executive officer compensation, advisory frequency vote on compensation (one year preferred), ratification of PricewaterhouseCoopers LLP as independent auditor, approval of an amendment to increase authorized common shares from 115 million to 215 million, and approval of an adjournment. All proposals passed with substantial majorities. This is material as it confirms board composition and shareholder approval of key governance and capital structure matters.
View raw filing on EDGAR →Southwest Airlines entered into an Increase Joinder Agreement on May 19, 2026, amending its Term Loan Credit Agreement to add $1.0 billion in incremental term loans, bringing total outstanding principal to $1.5 billion. The new debt is secured by aircraft collateral and materially increases the company's leverage.
View raw filing on EDGAR →Sabre issued $150 million of exchangeable senior notes convertible into common stock at an initial exchange price of approximately $2.24 per share in a private placement relying on Section 4(a)(2) exemption. The exchangeable notes create significant dilution potential of 67–87 million shares upon exchange, with net proceeds used to repurchase $100 million of existing exchangeable notes and retire the remaining $50 million, representing a material capital structure transaction.
View raw filing on EDGAR →The Compensation Committee approved long-term incentive compensation arrangements for named executive officers, including performance restricted stock units (PRSUs) and restricted stock grants with dollar values ranging from $175,000 to $1,250,000 per executive and specified vesting schedules.
View raw filing on EDGAR →Shareholders voted at the Annual Meeting held on May 14, 2026, approving four proposals: election of nine directors, ratification of Deloitte & Touche LLP as independent auditor, re-approval of the 2024 Long-Term Incentive Plan, and an advisory vote on named executive officer compensation.
View raw filing on EDGAR →ACCO Brands held its Annual Meeting of stockholders with voting results on four proposals: election of nine directors, ratification of KPMG LLP as independent auditor, advisory vote on named executive officer compensation, and approval of an amendment to the 2022 Incentive Plan increasing available shares by 4,100,000 and eliminating fungible share counting ratios.
View raw filing on EDGAR →Wayne A. Stevens, President - Retail Banking of Trustmark Bank, notified the Boards of his intention to retire effective July 3, 2026. While the disclosure also mentions acceleration of vesting of restricted stock units, the principal disclosed action is the departure of a long-tenured executive officer (40 years of service, Executive Officer since 2009). The compensatory element (RSU acceleration) is secondary and incidental to the retirement announcement.
View raw filing on EDGAR →This is a clear disclosure of shareholder meeting voting results under Item 5.07. The filing reports results on three proposals: election of eleven directors (all elected), advisory vote on named executive officer compensation (passed), and ratification of auditor Plante & Moran, LLC (passed). These are routine but material governance matters that affect investor understanding of board composition and corporate oversight.
View raw filing on EDGAR →